BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9231936)

  • 1. Translation of clinical and neuropsychological instruments into French: the CERAD experience.
    Demers P; Robillard A; Laflèche G; Nash F; Heyman A; Fillenbaum G
    Age Ageing; 1994 Nov; 23(6):449-51. PubMed ID: 9231936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-home assessment of dementia by nurses: experience using the CERAD evaluations. Consortium to Establish a Registry for Alzheimer's Disease.
    Trapp-Moen B; Tyrey M; Cook G; Heyman A; Fillenbaum GG
    Gerontologist; 2001 Jun; 41(3):406-9. PubMed ID: 11405439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frontotemporal dementia, semantic dementia, and Alzheimer's disease: the contribution of standard neuropsychological tests to differential diagnosis.
    Diehl J; Monsch AU; Aebi C; Wagenpfeil S; Krapp S; Grimmer T; Seeley W; Förstl H; Kurz A
    J Geriatr Psychiatry Neurol; 2005 Mar; 18(1):39-44. PubMed ID: 15681627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of the Korean version of the Consortium to Establish a Registry for Alzheimer's Disease Assessment Packet (CERAD-K): clinical and neuropsychological assessment batteries.
    Lee JH; Lee KU; Lee DY; Kim KW; Jhoo JH; Kim JH; Lee KH; Kim SY; Han SH; Woo JI
    J Gerontol B Psychol Sci Soc Sci; 2002 Jan; 57(1):P47-53. PubMed ID: 11773223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive decline in patients with Alzheimer's disease, vascular dementia and senile dementia of Lewy body type.
    Ballard C; Patel A; Oyebode F; Wilcock G
    Age Ageing; 1996 May; 25(3):209-13. PubMed ID: 8670554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CERAD (Consortium to Establish a Registry for Alzheimer's Disease) Neuropsychology Assessment Battery: 35 Years and Counting.
    Fillenbaum GG; Mohs R
    J Alzheimers Dis; 2023; 93(1):1-27. PubMed ID: 36938738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total scores of the CERAD neuropsychological assessment battery: validation for mild cognitive impairment and dementia patients with diverse etiologies.
    Seo EH; Lee DY; Lee JH; Choo IH; Kim JW; Kim SG; Park SY; Shin JH; Do YJ; Yoon JC; Jhoo JH; Kim KW; Woo JI
    Am J Geriatr Psychiatry; 2010 Sep; 18(9):801-9. PubMed ID: 20220577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late preterm birth and neurocognitive performance in late adulthood: a birth cohort study.
    Heinonen K; Eriksson JG; Lahti J; Kajantie E; Pesonen AK; Tuovinen S; Osmond C; Raikkonen K
    Pediatrics; 2015 Apr; 135(4):e818-25. PubMed ID: 25733746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The assessment of changes in cognitive functioning: age-, education-, and gender-specific reliable change indices for older adults tested on the CERAD-NP battery: results of the German Study on Ageing, Cognition, and Dementia in Primary Care Patients (AgeCoDe).
    Stein J; Luppa M; Luck T; Maier W; Wagner M; Daerr M; van den Bussche H; Zimmermann T; Köhler M; Bickel H; Mösch E; Weyerer S; Kaufeler T; Pentzek M; Wiese B; Wollny A; König HH; Riedel-Heller SG
    Am J Geriatr Psychiatry; 2012 Jan; 20(1):84-97. PubMed ID: 22183013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Norms and the effects of demographic variables on a neuropsychological battery for use in healthy ageing Australian populations.
    Collie A; Shafiq-Antonacci R; Maruff P; Tyler P; Currie J
    Aust N Z J Psychiatry; 1999 Aug; 33(4):568-75. PubMed ID: 10483853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the Chinese version of the Psychogeriatric Assessment Scales (PAS).
    Jia X; Li S; Chen C; Zhang W
    Int J Geriatr Psychiatry; 2000 Nov; 15(11):1075-6. PubMed ID: 11113990
    [No Abstract]   [Full Text] [Related]  

  • 13. Latent structure methods for estimating item bias, item validity and prevalence using cognitive and other geriatric screening measures.
    Teresi JA; Golden RR
    Alzheimer Dis Assoc Disord; 1994; 8 Suppl 1():S291-8. PubMed ID: 8068271
    [No Abstract]   [Full Text] [Related]  

  • 14. Can the sensitivity of the Alzheimer's Disease Assessment Scale be increased?
    Mattes JA
    Am J Geriatr Psychiatry; 1997; 5(3):258-60. PubMed ID: 9209568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychometric properties and factor structure of an expanded CERAD neuropsychological battery in an elderly VA sample.
    Jones SN; Ayers CR
    Arch Clin Neuropsychol; 2006 May; 21(4):359-65. PubMed ID: 16766158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease: correlational analysis of three screening tests and three behavioral scales.
    Villardita C; Lomeo C
    Acta Neurol Scand; 1992 Dec; 86(6):603-8. PubMed ID: 1481648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of Mild Cognitive Impairment Using the Thai Version of the Consortium to Establish a Registry for Alzheimer's Disease Tests: A Multivariate and Machine Learning Study.
    Tunvirachaisakul C; Supasitthumrong T; Tangwongchai S; Hemrunroj S; Chuchuen P; Tawankanjanachot I; Likitchareon Y; Phanthumchinda K; Sriswasdi S; Maes M
    Dement Geriatr Cogn Disord; 2018; 45(1-2):38-48. PubMed ID: 29617684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The behavioral pathology in Alzheimer's Disease Scale (BEHAVE-AD): factor structure among community-dwelling Alzheimer's disease patients.
    Harwood DG; Ownby RL; Barker WW; Duara R
    Int J Geriatr Psychiatry; 1998 Nov; 13(11):793-800. PubMed ID: 9850876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semantic memory impairment in the earliest phases of Alzheimer's disease.
    Vogel A; Gade A; Stokholm J; Waldemar G
    Dement Geriatr Cogn Disord; 2005; 19(2-3):75-81. PubMed ID: 15572875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Psychometric properties of the French version of the Modified Mini-Mental State (3MS) in elderly patients evaluated in geriatric psychiatry].
    Cappeliez P; Quintal M; Blouin M; Gagné S; Bourgeois A; Finlay M; Robillard A
    Can J Psychiatry; 1996 Mar; 41(2):114-21. PubMed ID: 8705957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.